Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/12/2022 17 1
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
Tenofovir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 4 3
Emtricitabine Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 2 2
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Siltuximab Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/29/2021 2 1